T 1524/23 (Multivalent PCV2 composition/BOEHRINGER INGELHEIM) of 11.09.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T152423.20250911
- Date of decision
- 11 September 2025
- Case number
- T 1524/23
- Petition for review of
- -
- Application number
- 17208901.3
- IPC class
- A61K 39/04A61K 39/12A61K 39/295
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Multivalent PCV2 immunogenic compositions and methods of producing such compositions
- Applicant name
- Boehringer Ingelheim Animal Health USA Inc.
- Opponent name
- Laboratorios Hipra, S.A.
Elanco US Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Inventive step - (no)
Amendment to appeal case - taken into account (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.